Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,116.7
-9.4 (-0.30%)

 

  • STI Straits Times Index
    3,116.7
    -9.4 (-0.30%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.7
    -5.8 (-0.37%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,712.2
    -136.3 (-0.51%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,939.2
    -38.1 (-1.28%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,492.7
    40.8 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,189.0
    8.0 (0.13%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,060.7
    -17.2 (-0.83%)
    Index delayed 20 minutes
  • XAO XAO
    6,758.4
    -33.1 (-0.49%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 660.8M
  • Value: 485.1M
  • Rise: 90
  • Fall: 141
  • Unch: 601

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.001-0.001
Rex Intl0.090+0.002
ThaiBev0.910+0.035
Spackman0.015-0.001
Genting Sing0.920-0.005
YZJ Shipbldg SGD0.940-0.010
AEM1.270+0.010
Synagie0.137+0.005
Y Ventures0.113+0.002
NetLink NBN Tr0.910-

World Indices

World Indices
Name Last Change
Nasdaq 8,156.9 +32.7
HSI 26,682.0 -166.5
HSCEI 10,527.9 -60.3
Jakarta 6,187.5 +6.5
Nikkei 225 22,492.7 +40.8
SSE Comp 2,938.1 -39.2
Shanghai A 3,078.2 -41.1
Shanghai B 263.8 -3.3
PSE Comp 0.0
KOSPI 2,060.7 -17.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ADVERUM BIOTECHNOLOGIES INC ADVERUM BIOTECHNOLOGIES
Updated on 17 Oct 2019 (End of trading day)
Last (USD): 7.050 Change: +0.200 High: 7.160 Remarks: -
Change (%): +2.92 Low: 6.700
Open 6.900 Yesterday's Close 6.85
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,448,924 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.12671 Trailing EPS (USD) e -1.02483 NAV (USD) b 2.7574
PE a - Trailing PE f - Price / NAV b 2.5568
Dividend (USD) d - Cash In Hand (USD) g 1.5174 Issued & Paid-up Shares c 64,459,200
Dividend Yield (%) d - Price / Cash In Hand g 4.646 Treasury Shares h -
Beta - 75 Daysi -1.495 R-Squared - 75 Days(%)i 4.15 Market Cap (M) 454.437
Beta - 500 Daysi -0.175 R-Squared - 500 Days (%)i 0.13 Enterprise Value (M) 302.541
Piotroski F Score 3 Exchange Code ADVM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 115.09 Free Float (%) 80.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 04 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 May 2016.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ADVERUM BIOTECHNOLOGIES INC NASDAQ 454.437 - - 2.5568 -
Industry Biotechnology NASDAQ 2,176.875 133.541 102.282 5.1195 0.805
Local Peer AMGEN INC NASDAQ 122,075.136 14.543 15.340 11.3095 2.723
Local Peer GILEAD SCIENCES INC NASDAQ 82,610.534 15.144 13.872 3.6527 3.538
Local Peer CELGENE CORP NASDAQ 72,149.834 17.832 13.688 7.1784 -
Local Peer ILLUMINA INC NASDAQ 45,650.850 55.267 48.668 10.5380 -
Local Peer VERTEX PHARMACEUTICAL NASDAQ 45,680.260 21.790 20.623 9.0100 -
Local Peer BIOGEN INC NASDAQ 41,611.243 9.392 7.860 3.2125 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,140.839 13.558 16.016 3.3970 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,420.458 288.922 16.812 2.2060 -
Local Peer INCYTE CORPORATION NASDAQ 16,652.638 152.089 54.444 7.4104 -
Local Peer SEATTLE GENETICS INC NASDAQ 14,512.086 - - 11.4104 -
Local Peer EXACT SCIENCES CORP NASDAQ 12,610.544 - - 16.4730 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 12,185.538 - - 4.1154 -
Other Local Peers GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), REPLIGEN CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), GENOMIC HEALTH INC (NASDAQ), NATERA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), 10X GENOMICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), OMEROS CORP (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VANDA PHARMACE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), PERSONALIS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), XBIOTECH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), MEDICINOVA INC (NASDAQ), DERMIRA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), ARDELYX INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), COMPUGEN (NASDAQ), RESTORBIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), KAMADA (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AFFIMED N V (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), XOMA CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), IMV INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SESEN BIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), VACCINEX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CURIS INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), EQUILLIUM INC (NASDAQ), ORGENESIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), VERMILLION INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SAVARA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), BIOCARDIA INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SENESTECH INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), OCUGEN INC (NASDAQ), SOLIGENIX INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), BIOCEPT INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), VAXART INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TROVAGENE INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), NEURALSTEM INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Global Peer CSL ASX 114,640.245 42.730 42.730 15.3198 1.051
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,185.343 73.371 21.628 4.8842 0.817
Global Peer SINO BIOPHARM HKEx 139,587.119 13.027 13.445 4.1009 0.659
Global Peer WUXI BIO HKEx 102,926.107 137.803 107.730 10.5950 -
Global Peer BEIGENE HKEx 61,976.448 - - 5.1053 -
Global Peer 3SBIO HKEx 35,135.516 23.226 28.270 3.4630 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer GENSCRIPT BIO HKEx 30,143.825 181.289 - 8.5006 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,795.172 44.580 - 2.8266 -
Other Global Peers FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), HAOHAI BIOTEC (HKEx), AVITA MEDICAL LTD (ASX), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), CKLIFE SCIENCES (HKEx), ARCUS BIOSCIENCES INC (NYSE), KADMON HLDGS INC (NYSE), LEE'S PHARM (HKEx), NEXT SCIENCE LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), 22ND CENTURY GROUP INC (NYSE American), PFENEX INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), RESAPP HEALTH LIMITED (ASX), BBI LIFE SCI (HKEx), ENZO BIOCHEM INC (NYSE), UNI-BIO GROUP (HKEx), LINEAGE CELL THERAPEUTICS INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NANOVIRICIDES INC (NYSE American), PHYLOGICA LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PORT (SET), IMUGENE LIMITED (ASX), CT ENTERPRISE (HKEx), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), BIONOMICS LTD (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), IBIO INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), RHINOMED LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), ISORAY INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), PATRYS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), IMMURON LIMITED (ASX), REGENEUS LTD (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CELLMID LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MEDIBIO LIMITED (ASX), HAO WEN HLDGS (HKEx), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), AIM IMMUNOTECH INC (NYSE American), AVECHO BIOTECHNOLOGY LTD (ASX), MEGASUN (Bursa), TBG DIAGNOSTICS LTD (ASX), QT Vascular (SGX), CCP TECHNOLOGIES LTD (ASX), NOVITA HEALTHCARE LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.760
+33.27 %
10 Days -+1.480
+26.57 %
20 Days -+0.610
+9.47 %
Medium Term Return 3 Months --6.920
-49.53 %
6 Months -+1.070
+17.89 %
1 Year -+2.560
+57.02 %
Long Term Return 2 Years -+3.575
+102.88 %
3 Years -+3.900
+123.81 %
Annualised Return Annualised --
+30.81 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.620 - 16.383 Change From 1 Year Low +4.430 % Change From 1 Year Low (%) +169.08
Change From 1 Year High -9.333 % Change From 1 Year High (%) -56.97
2 Years Range 2.620 - 16.383 Change From 2 Years Low +4.430 % Change From 2 Years Low (%) +169.08
Change From 2 Years High -9.333 % Change From 2 Years High (%) -56.97
5 Years Range 2.400 - 16.383 Change From 5 Years Low +4.650 % Change From 5 Years Low (%) +193.75
Change From 5 Years High -9.333 % Change From 5 Years High (%) -56.97
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with sight-threatening ophthalmic diseases. It focuses on treatment of wet age-related macular degeneration, alpha-1 antitrypsin deficiency, hereditary angioedema, friedreich's ataxia, severe allergy, color vision deficiency, and juvenile x-linked retinoschisis. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr. and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Menlo Park, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
17 Oct 2019 6.900 7.160 6.700 7.050 1,448,924 -
16 Oct 2019 6.340 7.080 6.230 6.850 1,883,201 -
15 Oct 2019 6.130 6.710 6.110 6.375 2,123,960 -
14 Oct 2019 5.540 6.350 5.490 6.090 3,954,672 -
11 Oct 2019 5.230 5.410 5.170 5.290 1,408,790 -
10 Oct 2019 5.160 5.250 4.960 5.170 1,290,204 -
09 Oct 2019 5.630 5.650 5.100 5.120 1,044,461 -
08 Oct 2019 5.550 5.730 5.460 5.590 881,089 -
07 Oct 2019 5.580 5.760 5.500 5.610 747,745 -
04 Oct 2019 5.570 5.930 5.550 5.570 788,814 -
03 Oct 2019 5.630 5.650 5.330 5.540 1,246,400 -
02 Oct 2019 5.200 5.660 5.030 5.625 1,296,419 -
01 Oct 2019 5.500 5.600 5.145 5.250 1,342,716 -
30 Sep 2019 5.420 5.600 5.290 5.450 1,311,455 -
27 Sep 2019 5.250 5.980 5.190 5.430 2,010,778 -
26 Sep 2019 5.470 5.540 5.160 5.240 1,406,432 -
25 Sep 2019 5.550 5.650 5.330 5.485 890,639 -
24 Sep 2019 5.810 5.860 5.375 5.580 1,951,668 -
23 Sep 2019 6.460 6.690 5.730 5.770 1,856,433 -
20 Sep 2019 6.190 6.670 5.940 6.440 9,581,818 -
19 Sep 2019 6.170 6.520 6.060 6.180 1,781,643 -
18 Sep 2019 6.220 6.230 5.950 6.190 1,911,968 -
Summary
Current 2 Weeks
(04 Oct 2019 to 17 Oct 2019)
5.570 7.160 4.960 7.050 15,571,860 -
Previous 2 Weeks
(20 Sep 2019 to 03 Oct 2019)
6.190 7.160 4.960 5.540 22,894,758 -
4 Weeks from
(22 Aug 2019 to 19 Sep 2019)
11.800 11.850 4.960 6.180 63,958,697 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.